Table 2 LGE data in asymptomatic and symptomatic DMD carriers
From: Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers
Patient | LGE | LGEq (ml) | LGE (%) |
|---|---|---|---|
Asymptomatic | Â | Â | Â |
1 | - | 0 | 0 |
2 | - | 0 | 0 |
3 | - | 0 | 0 |
4 | - | 0 | 0 |
5 | + sepi | 2 | 2 |
6 | + mid/sepi | 3 | 2,6 |
7 | - | 0 | 0 |
8 | - | 0 | 0 |
9 | - | 0 | 0 |
10 | - | 0 | 0 |
11 | - | 0 | 0 |
12 | - | 0 | 0 |
13 | - | 0 | 0 |
14 | - | 0 | 0 |
15 | + mid | 2 | 1,6 |
16 | + sepi | 2 | 2 |
17 | + sepi | 2 | 1,6 |
18 | + sepi | 2 | 1,6 |
19 | + sepi | 1 | 1 |
20 | + mid/sepi | 2 | 2 |
21 | - | 0 | 0 |
Symptomatic | Â | Â | Â |
1 | + mid/sepi | 1 | 1 |
2 | - | 0 | 0 |
3 | + mid | 2 | 2,3 |
4 | + sepi | 3 | 3 |
5 | - | 0 | 0 |
6 | + mid | 4 | 4 |
7 | + mid/sepi | 3 | 3 |
8 | - | 0 | 0 |
9 | + mid/sepi | 3,5 | 3,5 |